Skip to main content
. 2016 Jul 14;22(26):6065–6075. doi: 10.3748/wjg.v22.i26.6065

Table 3.

Risk of development of stent-related event increased with longer follow-up period in the absence of competing event (death)

Time-point of follow-up since first biliary stenting Estimated risk of development of SRE rate for all patients
3 mo 11.5% (95%CI: 6.5-19.7)
6 mo 32.0% (95%CI: 23.5-42.7)
12 mo 48.6% (95%CI: 37.5-61)
18 mo 59.9% (95%CI: 44-76.5)
24 mo 79.9% (95%CI: 48.03-98.1)

SRE: Stent-related event.